title: Modulating toll-like receptor 7 and 9 responses as therapy for allergy and autoimmunity.
abstract: Type I allergic diseases, such as allergic rhinitis and asthma, depend on allergen-induced T-helper type 2 (Th2) cells and IgE-secreting plasma cells. Fortunately, this harmful immune response can be modified by engaging Toll-like receptor (TLR)7 and TLR9, offering hopes to allergy sufferers. While clinical trials employing synthetic ligands for TLR7 or TLR9 are under way, one can wonder whether TLR7 or TLR9 engagements may trigger inadvertent autoreactivity and/or Th1-/Th17-mediated tissue pathology. To neutralize such danger, we have pioneered the development of potent TLR9 pathway antagonists, inhibitory oligonucleotides (INH-ODNs), which work in a sequence-specific manner. Interestingly, INH-ODNs also have TLR7-inhibitory properties; however, these effects appear to be sequence independent and phosphorothioate backbone dependent. In B cells, co-engagement of the B-cell receptor for antigen and TLR7 or TLR9 may influence how INH-ODNs impose their regulatory effects. INH-ODNs block TLR9 activation by competitively antagonizing ligand binding to proteolytically cleaved C-terminal TLR9 fragment. One may envision future use of INH-ODNs in systemic autoimmune diseases, DNA-mediated sepsis, or other situations in which chronic inflammation results from abnormal TLR7- and/or TLR9-mediated immune activation.
authors.affiliation: Indiana Institute of Immunology, Allergy, and Asthma, Kokomo, IN 46902, USA. damirmatesic@yahoo.com
authors.forename: Damir
authors.initials: D
authors.lastname: Matesic
authors.forename: Aleksander
authors.initials: A
authors.lastname: Lenert
authors.forename: Petar
authors.initials: P
authors.lastname: Lenert
mesh_terms: D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism; D015551:Autoimmunity / Q000187:drug effects* / Q000276:immunology; D001667:Binding, Competitive; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism; D009841:Oligonucleotides / Q000378:metabolism; D051199:Toll-Like Receptor 7 / Q000819:agonists* / Q000037:antagonists & inhibitors* / Q000276:immunology / Q000378:metabolism; D051217:Toll-Like Receptor 9 / Q000819:agonists* / Q000276:immunology / Q000378:metabolism
chemical_list: D009841:Oligonucleotides; D051199:Toll-Like Receptor 7; D051217:Toll-Like Receptor 9
references.citation: Lab Invest. 1970 Dec;23(6):628-34
references.pmid: 5312472
references.citation: Arthritis Rheum. 2003 Oct;48(10):2888-97
references.pmid: 14558095
references.citation: Arthritis Res Ther. 2006;8(1):203
references.pmid: 16542467
references.citation: Blood. 2009 Jan 8;113(2):377-88
references.pmid: 18824599
references.citation: J Immunol. 2007 Jun 15;178(12):7805-13
references.pmid: 17548618
references.citation: J Immunol. 2005 Apr 15;174(8):4579-83
references.pmid: 15814679
references.citation: Cancer Prev Res (Phila). 2011 May;4(5):752-7
references.pmid: 21367957
references.citation: J Autoimmun. 2010 Jun;34(4):339-48
references.pmid: 19944565
references.citation: Immunity. 2009 Nov 20;31(5):737-48
references.pmid: 19879164
references.citation: J Immunol. 2008 Jun 1;180(11):7648-54
references.pmid: 18490767
references.citation: J Clin Immunol. 2005 Jan;25(1):29-40
references.pmid: 15742155
references.citation: J Clin Invest. 2010 Oct;120(10):3651-62
references.pmid: 20811154
references.citation: J Clin Invest. 2004 Jul;114(2):270-9
references.pmid: 15254594
references.citation: Trends Immunol. 2001 Aug;22(8):427-31
references.pmid: 11473831
references.citation: Mediators Inflamm. 2010;2010:986596
references.pmid: 20490286
references.citation: J Immunol. 2011 Apr 15;186(8):4707-15
references.pmid: 21389257
references.citation: FASEB J. 2004 Mar;18(3):534-6
references.pmid: 14734643
references.citation: Immunology. 2008 Jan;123(1):118-28
references.pmid: 17961163
references.citation: J Immunol. 2010 Feb 15;184(4):2148-55
references.pmid: 20089705
references.citation: J Immunol. 2011 Jan 1;186(1):284-90
references.pmid: 21131420
references.citation: J Am Soc Nephrol. 2006 Jan;17(1):141-9
references.pmid: 16280469
references.citation: J Exp Med. 2005 Dec 5;202(11):1575-85
references.pmid: 16330816
references.citation: Proc Natl Acad Sci U S A. 2010 May 25;107(21):9813-8
references.pmid: 20439745
references.citation: J Allergy Clin Immunol. 1999 Dec;104(6):1258-64
references.pmid: 10589010
references.citation: Am J Respir Crit Care Med. 2010 Jun 1;181(11):1207-16
references.pmid: 20224068
references.citation: J Immunol. 2003 Aug 1;171(3):1393-400
references.pmid: 12874230
references.citation: Clin Exp Allergy. 2010 Apr;40(4):598-606
references.pmid: 20184605
references.citation: Int Immunol. 2005 Apr;17(4):411-20
references.pmid: 15746247
references.citation: Clin Diagn Lab Immunol. 2002 Nov;9(6):1260-9
references.pmid: 12414759
references.citation: Arthritis Rheum. 2003 Jun;48(6):1701-7
references.pmid: 12794839
references.citation: Nature. 2008 Dec 4;456(7222):658-62
references.pmid: 18820679
references.citation: Nature. 2000 Dec 7;408(6813):740-5
references.pmid: 11130078
references.citation: Am J Physiol Lung Cell Mol Physiol. 2002 Jul;283(1):L170-9
references.pmid: 12060574
references.citation: EMBO J. 1998 Nov 2;17(21):6230-40
references.pmid: 9799232
references.citation: Immunol Rev. 2005 Apr;204:27-42
references.pmid: 15790348
references.citation: J Immunol. 2009 Nov 15;183(10):6262-8
references.pmid: 19864612
references.citation: Science. 2006 Jun 16;312(5780):1669-72
references.pmid: 16709748
references.citation: Clin Exp Immunol. 2010 Aug;161(2):208-22
references.pmid: 20456414
references.citation: Allergy. 2008 Nov;63(11):1455-63
references.pmid: 18925882
references.citation: Autoimmunity. 2010 Mar;43(2):140-55
references.pmid: 19845477
references.citation: J Immunol. 2005 May 1;174(9):5193-200
references.pmid: 15843514
references.citation: Arthritis Rheum. 2005 Feb;52(2):651-8
references.pmid: 15692999
references.citation: Drug News Perspect. 2008 Oct;21(8):434-9
references.pmid: 19034349
references.citation: Eur J Immunol. 2002 May;32(5):1212-22
references.pmid: 11981808
references.citation: Curr Opin Immunol. 2011 Feb;23(1):3-9
references.pmid: 21146971
references.citation: Immunol Cell Biol. 2011 May;89(4):517-25
references.pmid: 20921967
references.citation: Immunity. 2008 Jun;28(6):799-809
references.pmid: 18513998
references.citation: J Allergy Clin Immunol. 2002 Dec;110(6):867-72
references.pmid: 12464952
references.citation: J Immunol. 2011 Apr 15;186(8):4794-804
references.pmid: 21398612
references.citation: Eur Respir J. 2010 Jan;35(1):64-71
references.pmid: 19643938
references.citation: J Immunol. 1994 Apr 1;152(7):3685-92
references.pmid: 8144943
references.citation: J Am Soc Nephrol. 2005 Nov;16(11):3273-80
references.pmid: 16176997
references.citation: J Leukoc Biol. 2002 Dec;72(6):1154-63
references.pmid: 12488497
references.citation: Int Immunol. 2011 Mar;23(3):203-14
references.pmid: 21393636
references.citation: Immunol Res. 2007;39(1-3):4-14
references.pmid: 17917051
references.citation: J Immunol. 2011 Apr 1;186(7):4433-42
references.pmid: 21335488
references.citation: Crit Rev Immunol. 2006;26(6):527-44
references.pmid: 17341193
references.citation: J Exp Med. 2005 Oct 17;202(8):1131-9
references.pmid: 16230478
references.citation: J Exp Med. 2010 Dec 20;207(13):2931-42
references.pmid: 21115693
references.citation: J Immunol. 2007 Dec 1;179(11):7397-405
references.pmid: 18025183
references.citation: Nature. 2008 Mar 13;452(7184):234-8
references.pmid: 18305481
references.citation: J Am Soc Nephrol. 2007 Jun;18(6):1721-31
references.pmid: 17460144
references.citation: Eur J Immunol. 2011 Oct;41(10):2820-7
references.pmid: 21766476
references.citation: J Immunol. 2010 Feb 15;184(4):1840-8
references.pmid: 20089701
references.citation: J Exp Med. 2000 Aug 21;192(4):595-600
references.pmid: 10952730
references.citation: Lupus. 2010 Oct;19(11):1290-301
references.pmid: 20605877
references.citation: Immunopharmacology. 1995 Feb;29(1):47-52
references.pmid: 7768671
references.citation: Clin Exp Immunol. 2005 Apr;140(1):1-10
references.pmid: 15762869
references.citation: J Immunol. 2004 Jun 1;172(11):6692-700
references.pmid: 15153485
references.citation: Nucleic Acids Res. 1983 Feb 11;11(3):853-70
references.pmid: 6188108
references.citation: Immunity. 2008 Mar;28(3):315-23
references.pmid: 18342006
references.citation: Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12061-6
references.pmid: 19574451
references.citation: J Immunol. 1998 Mar 15;160(6):2555-9
references.pmid: 9510150
references.citation: Nat Immunol. 2006 Feb;7(2):156-64
references.pmid: 16415873
references.citation: Arthritis Res Ther. 2009;11(3):R79
references.pmid: 19476613
references.citation: J Exp Med. 1998 Jun 15;187(12):2097-101
references.pmid: 9625770
references.citation: Immunity. 2006 Sep;25(3):417-28
references.pmid: 16973389
references.citation: J Immunol. 2009 Jun 15;182(12):7690-7
references.pmid: 19494293
references.citation: Nat Immunol. 2004 Feb;5(2):190-8
references.pmid: 14716310
references.citation: Lupus. 2003;12(11):838-45
references.pmid: 14667100
references.citation: Eur J Immunol. 2006 Jul;36(7):1815-26
references.pmid: 16783850
references.citation: J Immunol. 2003 Apr 1;170(7):3614-20
references.pmid: 12646625
references.citation: Nat Immunol. 2008 Dec;9(12):1407-14
references.pmid: 18931679
references.citation: Rheum Dis Clin North Am. 2004 Aug;30(3):505-27, viii-ix
references.pmid: 15261339
references.citation: J Exp Med. 1994 Apr 1;179(4):1317-30
references.pmid: 7511686
references.citation: Antisense Nucleic Acid Drug Dev. 2001 Aug;11(4):247-56
references.pmid: 11572601
references.citation: Pulm Pharmacol Ther. 2011 Apr;24(2):203-14
references.pmid: 21195789
references.citation: J Immunol. 1991 Sep 15;147(6):1759-64
references.pmid: 1890302
references.citation: J Immunol. 1998 Feb 1;160(3):1122-31
references.pmid: 9570525
references.citation: Nature. 2002 Apr 11;416(6881):603-7
references.pmid: 11948342
references.citation: Eur J Immunol. 2004 Sep;34(9):2541-50
references.pmid: 15307186
references.citation: Clin Exp Immunol. 2011 Mar;163(3):392-403
references.pmid: 21235537
references.citation: J Exp Med. 2011 Apr 11;208(4):643-51
references.pmid: 21402738
references.citation: Clin Immunol. 2000 Sep;96(3):198-204
references.pmid: 10964537
references.citation: Semin Immunol. 2011 Apr;23(2):106-12
references.pmid: 21306913
references.citation: Eur J Immunol. 2007 Dec;37(12):3582-6
references.pmid: 18034431
references.citation: Scand J Immunol. 2008 Jun;67(6):560-8
references.pmid: 18397197
references.citation: Arthritis Rheum. 2006 Jan;54(1):336-42
references.pmid: 16385525
references.citation: Am J Physiol Lung Cell Mol Physiol. 2003 Nov;285(5):L1137-46
references.pmid: 12857672
references.citation: J Med Chem. 2010 Apr 8;53(7):2964-72
references.pmid: 20232824
references.citation: Ann N Y Acad Sci. 2009 Sep;1175:80-8
references.pmid: 19796080
references.citation: J Exp Med. 2005 Nov 7;202(9):1171-7
references.pmid: 16260486
references.citation: Nat Immunol. 2007 Jul;8(7):772-9
references.pmid: 17572678
references.citation: J Clin Invest. 2011 Jan;121(1):57-69
references.pmid: 21157038
references.citation: J Immunol. 2006 Dec 1;177(11):8164-70
references.pmid: 17114492
references.citation: Immunol Rev. 2001 Feb;179:102-18
references.pmid: 11292014
references.citation: DNA Cell Biol. 2003 Oct;22(10):621-31
references.pmid: 14611683
references.citation: Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12631-6
references.pmid: 9770537
references.citation: Eur J Immunol. 2002 Jul;32(7):1958-68
references.pmid: 12115616
references.citation: Adv Drug Deliv Rev. 2009 Mar 28;61(3):256-62
references.pmid: 19167442
references.citation: Immunol Rev. 2007 Dec;220:251-69
references.pmid: 17979852
references.citation: Int Immunopharmacol. 2011 Aug;11(8):1032-7
references.pmid: 21376154
references.citation: J Clin Invest. 2011 May;121(5):1782-96
references.pmid: 21540549
references.citation: J Immunol. 2010 Feb 1;184(3):1159-67
references.pmid: 20026744
references.citation: Nature. 1995 Apr 6;374(6522):546-9
references.pmid: 7700380
references.citation: Curr Opin Allergy Clin Immunol. 2002 Dec;2(6):547-51
references.pmid: 14752340